INHERIT Study to Evaluate Proactive Genetic Testing in Cancer Patients
Tab Title Description
Describes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
- Jacksonville, Florida: 19-011472
NCT ID: NCT04456140
Sponsor Protocol Number: Inherit
About this study
The goal of this study is to evaluate the integration of cancer genetic testing into a community cancer clinical practice aimed toward patients of various ethnic populations in north Florida including, but not limited to, African Americans, Hispanic/Latino, Native American/Alaskan and Asian, by self-report.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
- Patients at least 18 years of age.
- Individuals diagnosed with any solid tumor cancer (stages 1-4) including, but not limited to, gastrointestinal, breast, gynecological, genitourinary, skin, CNS/brain, head/neck, musculoskeletal or cancer of unknown primary; and presenting to Mayo Clinic Embedded Cancer Center at St. Vincent’s Healthcare for clinical management/treatment.
- Blood collection is feasible (health, access and/or tolerability) for requested blood sample(s). Otherwise saliva samples may be obtained.
- Individuals have agreed to participate and signed the study informed consent form.
- Individuals under 18 years of age.
- Individuals who do not meet study inclusion criteria.
- Individuals with a hematologic malignancy.
- Patients who have had prior germline genetic testing involving a 40+ gene panel within the last 24 months at Mayo Clinic or St Vincent’s Healthcare and available for review by the research coordinator at time of consent.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
|Mayo Clinic Location
Mayo Clinic principal investigator
Jeremy Jones, M.D.
Closed for enrollment
Anishka Seymour B.S., M.S.
Publications are currently not available